Compile Data Set for Download or QSAR
Report error Found 122 Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase BTK [328-659]'
TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514921(US11098041, Example 151)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514922(US11098041, Example 152)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514923(US11098041, Example 153)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514780(US11098041, Example 2)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514783(US11098041, Example 5)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514784(US11098041, Example 6)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514788(US11098041, Example 10)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514789(US11098041, Example 11)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514898(US11098041, Example 125)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514899(US11098041, Example 126)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514900(US11098041, Example 127)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514901(US11098041, Example 129)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514902(US11098041, Example 130)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514904(US11098041, Example 132)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514908(US11098041, Example 136)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514911(US11098041, Example 139)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514912(US11098041, Example 140)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514913(US11098041, Example 142 | US11098041, Example 141)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514915(US11098041, Example 144)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514916(US11098041, Example 145)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514918(US11098041, Example 148)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514919(US11098041, Example 149)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514920(US11098041, Example 150)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514811(US11098041, Example 34)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514812(US11098041, Example 35)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514813(US11098041, Example 37)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514815(US11098041, Example 39)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514816(US11098041, Example 40)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514817(US11098041, Example 41)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514818(US11098041, Example 42)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514820(US11098041, Example 44)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514821(US11098041, Example 45)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514791(US11098041, Example 13)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514792(US11098041, Example 14)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514793(US11098041, Example 15)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514794(US11098041, Example 16)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514795(US11098041, Example 17)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514796(US11098041, Example 18)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514797(US11098041, Example 19)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514798(US11098041, Example 20)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514799(US11098041, Example 21)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514804(US11098041, Example 26)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514805(US11098041, Example 27)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514842(US11098041, Example 66)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514843(US11098041, Example 67)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514846(US11098041, Example 70)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514847(US11098041, Example 71)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514850(US11098041, Example 74)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514851(US11098041, Example 75)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [328-659](Human)
Merck Patent

US Patent
LigandPNGBDBM514852(US11098041, Example 76)
Affinity DataIC50: 100nMAssay Description:The protocol below describes a microfluidic, off-chip mobility shift kinase assay to measure inherent potency of compounds against BTK C481S enzyme. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2022
Entry Details
US Patent

Displayed 1 to 50 (of 122 total ) | Next | Last >>
Jump to: